Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis

Background Long‐term corticosteroid therapy is the standard of care for treatment of cardiac sarcoidosis (CS). The efficacy of long‐term corticosteroid‐sparing immunosuppression in CS is unknown. The goal of this study was to assess the efficacy of methotrexate with or without adalimumab for long‐te...

Full description

Bibliographic Details
Main Authors: David G. Rosenthal, Purvi Parwani, Tyler O. Murray, Bradley J. Petek, Bryan S. Benn, Teresa De Marco, Edward P. Gerstenfeld, Munir Janmohamed, Liviu Klein, Byron K. Lee, Joshua D. Moss, Melvin M. Scheinman, Henry H. Hsia, Van Selby, Laura L. Koth, Miguel H. Pampaloni, Julie Zikherman, Vasanth Vedantham
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
immunosuppression
sarcoidosis
ventricular arrhythmia
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.010952

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.010952

Similar Items